Nonetheless, our aim was pointed to verify the validation of the role of CD56 in the two categories of BNs and PMs with surgical follow-up excluding in this first study the category of indeterminate lesions which may not be significantly useful for a pilot study of ICC validation. Here, NCAM1 is linked to intrahepatic cholangiocarcinoma.